• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将灭活脊髓灰质炎疫苗(IPV)纳入南非常规免疫计划。

Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa.

机构信息

National Institute for Communicable Diseases/National Health Laboratory Service, Private Bag X4, Sandringham 2131, South Africa.

出版信息

Vaccine. 2012 Sep 7;30 Suppl 3:C35-7. doi: 10.1016/j.vaccine.2012.02.056.

DOI:10.1016/j.vaccine.2012.02.056
PMID:22939019
Abstract

South Africa is currently the only country on the African continent using inactivated polio vaccine (IPV) for routine immunization in a sequential schedule in combination with oral polio vaccine (OPV). IPV is a component of an injectable pentavalent vaccine introduced nationwide in April 2009 and administered according to EPI schedule at 6, 10 and 14 weeks with a booster dose at 18 months. OPV is administered at birth and together with the first IPV dose at 6 weeks, which stimulates gut immune system producing a memory IgA response (OPV), followed by IPV to minimize the risk of vaccine associated paralytic polio (VAPP). OPV is also given to all children under 5 years of age as part of regular mass immunizations campaigns. The decision to incorporate IPV into the routine schedule was not based on cost-effectiveness, which it is not. Other factors were taken into account: Firstly, the sequence benefits from the initial mucosal contact with live(vaccine) virus which promotes the IgA response from subsequent IPV, as well as herd immunity from OPV, together with the safety of IPV. Secondly, given the widespread and increasing use of IPV in the developed world, public acceptance of vaccination in general is enhanced in South Africa which is classified as an upper middle income developing country. Thirdly, to address equity concerns because of the growing use of IPV in the private sector. Fourthly, the advent of combination vaccines facilitated the incorporation of IPV into the EPI schedule.

摘要

南非目前是非洲大陆唯一在常规免疫中序贯使用灭活脊髓灰质炎疫苗(IPV)的国家,与口服脊髓灰质炎疫苗(OPV)联合使用。IPV 是 2009 年 4 月在全国范围内推出的一种五价注射疫苗的组成部分,按照 EPI 时间表在 6、10 和 14 周时进行接种,在 18 个月时进行加强针接种。OPV 在出生时接种,并与第 6 周时的第一针 IPV 同时接种,这会刺激肠道免疫系统产生记忆 IgA 反应(OPV),然后接种 IPV 以最大程度降低疫苗相关麻痹性脊髓灰质炎(VAPP)的风险。OPV 也会作为常规大规模免疫接种活动的一部分,用于所有 5 岁以下儿童。将 IPV 纳入常规免疫接种时间表的决定并非基于成本效益,因为它并非如此。还考虑了其他因素:首先,该顺序得益于与活(疫苗)病毒的初始粘膜接触,这促进了随后 IPV 的 IgA 反应,以及 OPV 的群体免疫力,以及 IPV 的安全性。其次,鉴于 IPV 在发达国家的广泛使用和不断增加,南非对疫苗接种的公众接受度普遍提高,南非被归类为中上收入发展中国家。第三,为了解决由于私营部门越来越多地使用 IPV 而引起的公平性问题。第四,联合疫苗的出现促进了 IPV 纳入 EPI 时间表。

相似文献

1
Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa.将灭活脊髓灰质炎疫苗(IPV)纳入南非常规免疫计划。
Vaccine. 2012 Sep 7;30 Suppl 3:C35-7. doi: 10.1016/j.vaccine.2012.02.056.
2
The cost-effectiveness of alternative polio immunization policies in South Africa.南非替代脊髓灰质炎免疫政策的成本效益
Vaccine. 2006 Jul 17;24(29-30):5670-8. doi: 10.1016/j.vaccine.2006.05.032.
3
Anomalous observations on IPV and OPV vaccination.关于脊灰灭活疫苗(IPV)和口服脊髓灰质炎疫苗(OPV)接种的异常观察结果。
Dev Biol (Basel). 2001;105:197-208.
4
[Inactivated poliovirus vaccine].[灭活脊髓灰质炎疫苗]
Nihon Rinsho. 2011 Sep;69(9):1604-8.
5
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防:采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
6
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.脊髓灰质炎疫苗。全球根除脊髓灰质炎的进展以及美国常规免疫接种建议的变化。
Pediatr Clin North Am. 2000 Apr;47(2):287-308. doi: 10.1016/s0031-3955(05)70208-x.
7
Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.引入灭活脊髓灰质炎疫苗以推进脊髓灰质炎根除终局战略计划;中国杭州,2010 - 2014年
Vaccine. 2017 Mar 1;35(9):1281-1286. doi: 10.1016/j.vaccine.2017.01.034. Epub 2017 Feb 1.
8
A developing country perspective on vaccine-associated paralytic poliomyelitis.发展中国家对疫苗相关麻痹型脊髓灰质炎的看法。
Bull World Health Organ. 2004 Jan;82(1):53-7; discussion 57-8. Epub 2004 Feb 26.
9
World wide experience with inactivated poliovirus vaccine.全球使用灭活脊髓灰质炎疫苗的经验。
Vaccine. 2008 Sep 15;26(39):4978-83. doi: 10.1016/j.vaccine.2008.07.026. Epub 2008 Aug 3.
10
Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.印度脊髓灰质炎免疫策略的预算影响:引入一剂灭活脊髓灰质炎疫苗和减少补充脊髓灰质炎免疫。
Public Health. 2017 Jan;142:31-38. doi: 10.1016/j.puhe.2016.10.016. Epub 2016 Nov 17.

引用本文的文献

1
High Detection Frequency of Vaccine-Associated Polioviruses and Non-Polio Enteroviruses in the Stools of Asymptomatic Infants from the Free State Province, South Africa.南非自由邦省无症状婴儿粪便中疫苗相关脊髓灰质炎病毒和非脊髓灰质炎肠道病毒的高检测频率
Microorganisms. 2024 Apr 30;12(5):920. doi: 10.3390/microorganisms12050920.
2
A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.一项社会生态学探索,旨在确定影响肯尼亚孕妇和哺乳期妇女 COVID-19 疫苗接种决策过程的因素。
Vaccine. 2022 Nov 28;40(50):7305-7311. doi: 10.1016/j.vaccine.2022.10.068. Epub 2022 Oct 31.
3
Sensitivity of the acute flaccid paralysis surveillance system for poliovirus in South Africa, 2016-2019.
2016 - 2019年南非脊髓灰质炎病毒急性弛缓性麻痹监测系统的敏感性
J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001441.
4
National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.国家决策引进新疫苗:系统评价,2010-2020 年。
Vaccine. 2021 Apr 1;39(14):1897-1909. doi: 10.1016/j.vaccine.2021.02.059. Epub 2021 Mar 6.
5
Maternal immunization in Malawi: A mixed methods study of community perceptions, programmatic considerations, and recommendations for future planning.马拉维的母婴免疫接种:一项社区认知、规划考虑因素的混合方法研究,以及对未来规划的建议。
Vaccine. 2019 Jul 26;37(32):4568-4575. doi: 10.1016/j.vaccine.2019.06.020.
6
Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.HIV 暴露和抗逆转录病毒治疗时机对婴儿三价减毒活脊灰疫苗免疫原性的影响。
PLoS One. 2019 Apr 19;14(4):e0215079. doi: 10.1371/journal.pone.0215079. eCollection 2019.
7
Development of a thermostable microneedle patch for polio vaccination.开发一种用于小儿麻痹症疫苗接种的耐热微针贴片。
Drug Deliv Transl Res. 2019 Feb;9(1):192-203. doi: 10.1007/s13346-018-00608-9.
8
Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April-November 2015.2015年4月至11月对尼日利亚卡诺州灭活脊髓灰质炎疫苗的引进与使用情况进行评估
J Infect Dis. 2017 Jul 1;216(suppl_1):S137-S145. doi: 10.1093/infdis/jix044.
9
Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study.MAL-ED队列研究中八个资源匮乏地区的疫苗接种覆盖率及对扩大免疫规划程序的依从性
Vaccine. 2017 Jan 11;35(3):443-451. doi: 10.1016/j.vaccine.2016.11.075. Epub 2016 Dec 18.
10
Polio inactivated vaccine costs into routine childhood immunization in Brazil.脊髓灰质炎灭活疫苗纳入巴西儿童常规免疫接种费用。
Rev Saude Publica. 2015;49:8. doi: 10.1590/s0034-8910.2015049005492. Epub 2015 Feb 27.